| 000 | 01634 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250517193706.0 | ||
| 264 | 0 | _c20180831 | |
| 008 | 201808s 0 0 eng d | ||
| 022 | _a1873-2747 | ||
| 024 | 7 |
_a10.1016/j.brainresbull.2018.01.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEsmaeili, Mohammad Hossein | |
| 245 | 0 | 0 |
_aATP-sensitive potassium-channel inhibitor glibenclamide attenuates HPA axis hyperactivity, depression- and anxiety-related symptoms in a rat model of Alzheimer's disease. _h[electronic resource] |
| 260 |
_bBrain research bulletin _c03 2018 |
||
| 300 |
_a265-276 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAlzheimer Disease _xdrug therapy |
| 650 | 0 | 4 | _aAmyloid beta-Peptides |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnxiety _xdrug therapy |
| 650 | 0 | 4 |
_aCorticosterone _xmetabolism |
| 650 | 0 | 4 |
_aDepression _xdrug therapy |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aGlyburide _xpharmacology |
| 650 | 0 | 4 |
_aHypothalamo-Hypophyseal System _xdrug effects |
| 650 | 0 | 4 |
_aKATP Channels _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNootropic Agents _xpharmacology |
| 650 | 0 | 4 | _aPeptide Fragments |
| 650 | 0 | 4 |
_aPituitary-Adrenal System _xdrug effects |
| 650 | 0 | 4 |
_aPotassium Channel Blockers _xpharmacology |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aStress, Psychological _xdrug therapy |
| 700 | 1 | _aBahari, Behnam | |
| 700 | 1 | _aSalari, Ali-Akbar | |
| 773 | 0 |
_tBrain research bulletin _gvol. 137 _gp. 265-276 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.brainresbull.2018.01.001 _zAvailable from publisher's website |
| 999 |
_c27954403 _d27954403 |
||